Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

Completed

Conditions studied: Hepatic Fibrogenesis, Hepatitis C

In brief

The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.

Key facts

Study ID

NCT00205075

Run by

University of Wisconsin, Madison

People needed

47

Starts

2004-08-01

Expected to finish

2008-06-01

Last updated by the study team

2015-12-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately

You may not qualify if…

• HIV co-infection
• Treated within the past 6 months
• History (hx) of other liver disease
• Alcohol use greater than 30 g/day or history of binge drinking in the last year
• Decompensated liver disease

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.